395 related articles for article (PubMed ID: 34482648)
1. Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Chen Z; Wu H; Yang H; Fan Y; Zhao S; Zhang M
Cancer Med; 2021 Oct; 10(20):7418-7439. PubMed ID: 34482648
[TBL] [Abstract][Full Text] [Related]
2. Development and Multi-Data Set Verification of an RNA Binding Protein Signature for Prognosis Prediction in Glioma.
Sheng C; Chen Z; Lei J; Zhu J; Song S
Front Med (Lausanne); 2021; 8():637803. PubMed ID: 33634155
[No Abstract] [Full Text] [Related]
3. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
6. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
8. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
Chen F; Wang Q; Zhou Y
BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
[TBL] [Abstract][Full Text] [Related]
9. Identification and classification of glioma subtypes based on RNA-binding proteins.
Liu X; Wu L; Wang L; Li Y
Comput Biol Med; 2024 May; 174():108404. PubMed ID: 38582000
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 6-RBP gene signature for a comprehensive analysis of glioma and ischemic stroke: Cognitive impairment and aging-related hypoxic stress.
Lin W; Wang Q; Chen Y; Wang N; Ni Q; Qi C; Wang Q; Zhu Y
Front Aging Neurosci; 2022; 14():951197. PubMed ID: 36118697
[TBL] [Abstract][Full Text] [Related]
11. Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.
Peng P; Chen ZR; Zhang XL; Guo DS; Zhang B; He XM; Wan F
Curr Med Sci; 2023 Feb; 43(1):156-165. PubMed ID: 36867360
[TBL] [Abstract][Full Text] [Related]
12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
14. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
Front Genet; 2021; 12():778715. PubMed ID: 34976013
[No Abstract] [Full Text] [Related]
15. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
17. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
Chen J; Hou C; Wang P; Yang Y; Zhou D
World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
[TBL] [Abstract][Full Text] [Related]
18. A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma.
Yang Y; Teng H; Zhang Y; Wang F; Tang L; Zhang C; Hu Z; Chen Y; Ge Y; Wang Z; Yu Y
Front Pharmacol; 2023; 14():1259051. PubMed ID: 38293671
[TBL] [Abstract][Full Text] [Related]
19. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
20. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
Front Genet; 2021; 12():768930. PubMed ID: 34733320
[No Abstract] [Full Text] [Related]
[Next] [New Search]